These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 1838916)
1. [Cilazapril, a new ACE inhibitor, in severe arterial hypertension]. Arcila Herrera H; Montero Cervantes L; Rivero Cárdenas NA; Osorio Guerreo MI; Flores Serrano AG; González Franco MF Arch Inst Cardiol Mex; 1991; 61(6):573-8. PubMed ID: 1838916 [TBL] [Abstract][Full Text] [Related]
2. The 24 h blood pressure responses of hypertensives to a once-a-day cilazapril regimen. Fernandez PG; Bolli P; Lee C Can J Cardiol; 1990 Mar; 6(2):53-8. PubMed ID: 2138051 [TBL] [Abstract][Full Text] [Related]
3. Antihypertensive, enzymatic, and hormonal activity of cilazapril, a new angiotensin-converting enzyme inhibitor in patients with mild to moderate essential hypertension. Sánchez RA; Traballi CA; Barclay CA; Gilbert HB; Muscará M; Giannone C; Moledo LI J Cardiovasc Pharmacol; 1988 Feb; 11(2):230-4. PubMed ID: 2452319 [TBL] [Abstract][Full Text] [Related]
4. [Cilazapril in the treatment of patients with arterial hypertension]. Talipova IZh; Zaslavskaia RM; Berkinbaev SF Klin Med (Mosk); 2002; 80(8):50-2. PubMed ID: 12360621 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of delapril plus manidipine compared with enalapril plus hydrochlorothiazide in mild to moderate essential hypertension: results of a randomized trial. Mugellini A; Dobovisek J; Planinc D; Cremonesi G; Fogari R Clin Ther; 2004 Sep; 26(9):1419-26. PubMed ID: 15531004 [TBL] [Abstract][Full Text] [Related]
6. Long-term evaluation of cilazapril in severe hypertension. Assessment of left ventricular and renal function. Sánchez RA; Traballi CA; Marcó EJ; Cianciulli T; Giannone CA; Ramiréz AJ Am J Med; 1989 Dec; 87(6B):56S-60S. PubMed ID: 2532462 [TBL] [Abstract][Full Text] [Related]
7. Cilazapril: a new non-thiol-containing angiotensin-converting enzyme inhibitor. Worldwide clinical experience in hypertension. Kögler P Am J Med; 1989 Dec; 87(6B):50S-55S. PubMed ID: 2532461 [TBL] [Abstract][Full Text] [Related]
8. Antihypertensive effects and pharmacokinetics of single and consecutive doses of cilazapril in hypertensive patients with normal and impaired renal function. Shionoiri H; Gotoh E; Takagi N; Takeda K; Yabana M; Kaneko Y J Cardiovasc Pharmacol; 1988 Feb; 11(2):242-9. PubMed ID: 2452321 [TBL] [Abstract][Full Text] [Related]
9. Antihypertensive treatment with cilazapril. Resting and exercise blood pressure, hormones and enzymes. Breithaupt K; Belz GG; Spielmanns DG; Neis W; Kirchner P Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):136-41. PubMed ID: 2159308 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of cilazapril compared with hydrochlorothiazide in the treatment of mild-to-moderate essential hypertension. Multicentre Study Group. Morgan TO Am J Med; 1989 Dec; 87(6B):37S-41S. PubMed ID: 2532459 [TBL] [Abstract][Full Text] [Related]
11. Cilazapril: an overview of its efficacy and safety in hypertension. Szucs T; Schneeweiss A Cardiology; 1992; 80(1):34-41. PubMed ID: 1532534 [TBL] [Abstract][Full Text] [Related]
12. [Reparative effects of ACE inhibitors on the heart]. Dietz R; Haberbosch W; Osterziel KJ; Förderer T; Busch C Klin Wochenschr; 1992; 69 Suppl 29():16-24. PubMed ID: 1535402 [TBL] [Abstract][Full Text] [Related]
13. Beta-blockers and ACE-inhibitors--further evidence for therapeutic benefit of this combination in hypertension. Erb KA; Breithaupt K; Belz GG J Hum Hypertens; 1990 Feb; 4(1):63. PubMed ID: 1971655 [No Abstract] [Full Text] [Related]
14. Effects of a fixed-dose ACE inhibitor-diuretic combination on ambulatory blood pressure and arterial properties in isolated systolic hypertension. Ferguson JM; Minas J; Siapantas S; Komesaroff PA; Sudhir K J Cardiovasc Pharmacol; 2008 Jun; 51(6):590-5. PubMed ID: 18520951 [TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of the acute and chronic effects of cilazapril and hydrochlorothiazide on diastolic cardiac function in hypertensive patients. Schneeweiss A; Rosenthal J; Marmor A J Hum Hypertens; 1990 Oct; 4(5):535-9. PubMed ID: 2149388 [TBL] [Abstract][Full Text] [Related]
16. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension. Levine B Curr Med Res Opin; 2001; 17(1):8-17. PubMed ID: 11464450 [TBL] [Abstract][Full Text] [Related]
17. Influence of the angiotensin converting enzyme inhibitor cilazapril, the beta-blocker propranolol and their combination on haemodynamics in hypertension. Belz GG; Breithaupt K; Erb K; Kleinbloesem CH; Wolf GK J Hypertens; 1989 Oct; 7(10):817-24. PubMed ID: 2531184 [TBL] [Abstract][Full Text] [Related]
18. [Effectiveness and tolerance of fosinopril in the treatment of arterial hypertension of mild and medium severity]. Rosolová H; Cech J; Sefrna F Vnitr Lek; 2001 Dec; 47(12):834-9. PubMed ID: 11826546 [TBL] [Abstract][Full Text] [Related]
19. Albuminuria in diabetes mellitus: relation to ambulatory versus office blood pressure and effects of cilazapril. Waeber B; Weidmann P; Wohler D; Le Bloch Y Am J Hypertens; 1996 Dec; 9(12 Pt 1):1220-7. PubMed ID: 8972894 [TBL] [Abstract][Full Text] [Related]
20. [Cilazapril replacing captopril in the therapy of medium-severe essential hypertension]. Kovács P; Juhász A; Gábeli T; Karányi Z; Polgár P; Paragh G; Lörincz I; Arnold C Orv Hetil; 1995 Oct; 136(42):2273-8. PubMed ID: 7478470 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]